Your shopping cart is currently empty

ALV1 is a molecular glue degrader that targets and degrades Ikaros (IKZF1) and Helios (IKZF2), with DC50 values of 2.5 nM and 10.3 nM, respectively. ALV1 binds to CRBN with an IC50 of 0.55 μM and induces the dimerization of CRBN and Helios. It can be used to investigate the properties and functions of regulatory T cells .

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $113 | - | In Stock | |
| 5 mg | $289 | - | In Stock | |
| 10 mg | $463 | - | In Stock | |
| 25 mg | $953 | - | In Stock | |
| 50 mg | $1,280 | - | In Stock | |
| 100 mg | $1,730 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $318 | - | In Stock |
| Description | ALV1 is a molecular glue degrader that targets and degrades Ikaros (IKZF1) and Helios (IKZF2), with DC50 values of 2.5 nM and 10.3 nM, respectively. ALV1 binds to CRBN with an IC50 of 0.55 μM and induces the dimerization of CRBN and Helios. It can be used to investigate the properties and functions of regulatory T cells . |
| Targets&IC50 | CRBN:0.55 μM, IKZF2:10.3 nM (DC₅₀), IKZF1:2.5 nM (DC₅₀) |
| In vitro | ALV1 (0–10 μM, 4–18 hours) induces degradation of Ikaros and Helios and promotes IL‑2 secretion in Jurkat cells [1]. ALV1 (1 μM, 24 hours) effectively degrades Ikaros and Helios in Treg cells isolated from human peripheral blood [1]. ALV1 (0.1–10 μM, 4 hours) induces degradation of Ikaros and Helios without affecting the stability of GSPT1 in Jurkat cells [1]. ALV1 (1 μM, 4 hours) induces Helios degradation with no detectable off‑target effects in Jurkat cells [1]. ALV1 (1 μM, 18 hours) promotes IL‑2 secretion more strongly than lenalidomide in Jurkat cells, suggesting that Helios exerts a stronger inhibitory effect on IL‑2 production in this system [1]. |
| Molecular Weight | 494.93 |
| Formula | C25H23ClN4O5 |
| Cas No. | 2438124-79-7 |
| Smiles | O=C1C=C(NC2=CC=CC(=C2)CCC(=O)NC3=CC=C(C(Cl)=C3)C)C(=O)N1C4C(=O)NC(=O)CC4 |
| Storage | store at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (80.82 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.